Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Integrated Diagnostics launched to develop diagnostic tools and innovative biomarkers

Integrated Diagnostics launched officially today with more than $30 million in funding. A pre-eminent team of scientists and investors are behind the company, which was founded by renowned biotechnology innovator Dr. Leroy Hood. Integrated Diagnostics will focus on developing personalized and preventive diagnostics based on breakthroughs using genomic and proteomic technologies to identify organ-specific proteins.

14 Oct 2009

NIH awards research grants for NYU Langone Medical Center

NYU Langone Medical Center has been awarded more than $30 million in research grants from the National Institute of Health (NIH) for 86 research projects being conducted at NYU School of Medicine across a broad range of basic science and clinical departments.

14 Oct 2009

ADDF grant to support the evaluation of PPAR-sparing insulin sensitizers

Metabolic Solutions Development Company (MSDC) announced today that it has received a $100,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF) to support the evaluation of PPAR-sparing insulin sensitizers as a potential treatment for Alzheimer's disease.

14 Oct 2009

Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG

Vanda Pharmaceuticals Inc. announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults.

14 Oct 2009

AVANIR Pharmaceuticals announces results of Zenvia double-blind Phase III STAR trial

AVANIR Pharmaceuticals, Inc. today announced detailed results from the confirmatory double-blind Phase III STAR trial evaluating two doses of the investigational drug Zenvia™ (dextromethorphan/quinidine) compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying multiple sclerosis (MS) or amyotrophic lateral sclerosis (ALS).

14 Oct 2009

NIH awards Gladstone Institute consortium $3.7M for Huntington's disease research

The National Institutes of Health (NIH) has awarded a "Grand Opportunity" grant of $3.7 million to a consortium formed with the Gladstone Institute of Neurological Disease (GIND) and the Taube-Koret Center for Huntington's Disease Research to use stem cell technology to better understand Huntington's disease (HD) and to develop potential therapies.

14 Oct 2009

Johnson & Johnson announces financial results for the third quarter of 2009

Johnson & Johnson today announced sales of $15.1 billion for the third quarter of 2009, a decrease of 5.3% as compared to the third quarter of 2008. Operational results declined 2.8% and the negative impact of currency was 2.5%. Domestic sales declined 8.1%, while international sales declined 2.5%, reflecting operational growth of 2.4% and a negative currency impact of 4.9%.

13 Oct 2009

Discovery opens new possibility of designing drugs for amyotrophic lateral sclerosis

Researchers at Lund University, Sweden, have taken a snapshot of proteins changing shape, sticking together and creating structures that are believed to trigger deadly processes in the nervous system. The discovery opens the possibility of designing drugs for a devastating neurological disease, ALS.

13 Oct 2009

New mouse models resembles human ALS; may provide important tool for screening new drugs

A new mouse model of amyotrophic lateral sclerosis (ALS) closely resembles humans with the paralyzing disorder, researchers at Washington University School of Medicine in St. Louis report.

13 Oct 2009

Mouse model of ALS closely resembles humans with the paralyzing disorder, says report

A new mouse model of amyotrophic lateral sclerosis (ALS) closely resembles humans with the paralyzing disorder, researchers at Washington University School of Medicine in St. Louis report.

13 Oct 2009

Guidelines for treating amyotrophic lateral sclerosis identified

New guidelines from the American Academy of Neurology identify the most effective treatments for amyotrophic lateral sclerosis (ALS), often called Lou Gehrig's disease. The guidelines are published in the October 13, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology.

13 Oct 2009

Despite economic downturn, Senior Living Residences marches ahead

Boston-based Senior Living Residences (SLR), a company with a 15-year history of successful ownership, lease-up and management of senior housing communities, has further burnished its track record of robust lease-up of new assisted living facilities even as other companies in the senior housing industry are reporting the negative impact of the current economic downturn.

13 Oct 2009

Report shows that visual impairments are associated with the risk of death in older adults

Visual problems that cannot be corrected are associated with increased risk of death among individuals between the ages of 49 and 74, and all visual impairments may be associated with the risk of death in older adults, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

13 Oct 2009

Cognitive abilites other than memory may decline prior to clinical diagnosis in patients with Alzheimer's disease

Cognitive abilities other than memory, including visuospatial skills needed to perceive relationships between objects, may decline years prior to a clinical diagnosis in patients with Alzheimer's disease, according to a report in the October issue of Archives of Neurology, one of the JAMA/Archives journals.

13 Oct 2009

Holistic care needed for people with Alzheimer's disease and dementia

Whilst cognitive function can be improved by the medicines currently available for the treatment of dementias, the positive effects of improved socialibility, initiative and motivation on the patient and their carer as well as their capability of coping with everyday life should not be overlooked says a research report published by the Pharmacy Practice Research Trust (the Trust).

12 Oct 2009

The third “Exciting Biologies” meeting focuses on “Biology In Balance”

In a continuing series called “Exciting Biologies” Cell Press, Massachusetts General Hospital and La Fondation Ipsen collaborate to offer annual meetings designed to highlight emerging intersections in biomedical research and promote interactions between scientists from converging disciplines. This third meeting, held in Buenos Aires between the 8th and 10th of October, focused on “Biology in Balance”.

12 Oct 2009

Caring for Alzheimer's patients proves costly

Newsday reports that the high cost of caring for Alzheimer's patients "can easily deplete even the deepest bank account. Because the disease lasts so long - anywhere from two to 20 years, depending on the stage at diagnosis - and because the type of care needed often falls beyond the scope of government health care programs, families find themselves scrambling to find the money needed to maintain care for their loved one."

9 Oct 2009

Health policy research roundup

Urban Institute: Variation in Insurance Coverage Across Congressional Districts New Estimates from 2008 -- Drawing from data from the American Community Survey, the authors of this brief explore the variation in rates of uninsurance, public and private coverage across congressional districts.

9 Oct 2009

Brookdale Senior Living enters asset purchase agreement with affiliates of Sunrise Senior Living

Brookdale Senior Living Inc. today announced that it has entered into a definitive asset purchase agreement with affiliates of Sunrise Senior Living, Inc.to acquire 21 senior living communities that are currently owned by those affiliates for an aggregate purchase price of $204 million plus customary transaction expenses.

9 Oct 2009

AMHN to air new healthcare video segments of Saddle Ranch Productions on its network

AMHN, Inc., parent company of America’s Minority Health Network, Inc., announced today that Saddle Ranch Productions, Inc. ("Saddle Ranch Productions") completed new healthcare video segments to be immediately aired on its network.

9 Oct 2009

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Integrated Diagnostics launched to develop diagnostic tools and innovative biomarkers

NIH awards research grants for NYU Langone Medical Center

ADDF grant to support the evaluation of PPAR-sparing insulin sensitizers

Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG

AVANIR Pharmaceuticals announces results of Zenvia double-blind Phase III STAR trial

NIH awards Gladstone Institute consortium $3.7M for Huntington's disease research

Johnson & Johnson announces financial results for the third quarter of 2009

Discovery opens new possibility of designing drugs for amyotrophic lateral sclerosis

New mouse models resembles human ALS; may provide important tool for screening new drugs

Mouse model of ALS closely resembles humans with the paralyzing disorder, says report

Guidelines for treating amyotrophic lateral sclerosis identified

Despite economic downturn, Senior Living Residences marches ahead

Report shows that visual impairments are associated with the risk of death in older adults

Cognitive abilites other than memory may decline prior to clinical diagnosis in patients with Alzheimer's disease

Holistic care needed for people with Alzheimer's disease and dementia

The third “Exciting Biologies” meeting focuses on “Biology In Balance”

Caring for Alzheimer's patients proves costly

Health policy research roundup

Brookdale Senior Living enters asset purchase agreement with affiliates of Sunrise Senior Living

AMHN to air new healthcare video segments of Saddle Ranch Productions on its network

Innovation in neuroscience drug discovery - eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in